R&D The future of drug development: Integrating open source and ... Clinical trials for drug development are becoming increasingly complex, with numerous variables that must be identified and defined from the start.
Deep Dive The promise and pitfalls of molecular testing in oncology Great strides have been made in the diagnosis and treatment of cancer. However, a variety of challenges remain that frustrate both physicians and patients.
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.